Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR

Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR

Conditions: Severe Aortic Stenosis; Cardiogenic Shock; Cardiogenic Shock, ECMO; Trans-catheter Aortic Valve Implantation
Interventions: Device: Left Atrial Veno-Arterial Extracorporeal Membrane Oxygenation (LAVA-ECMO)
Sponsors: Atlantic Health System
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 31, 2025Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Comments